Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04022499 · ClinicalTrials.gov registry record · NA
Presessions for the National Diabetes Prevention Program
A NA study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 483
- Enrollment target
NCT04022499 is a NA study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 483 participants.
The verdict
NCT04022499, a NA study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 483 participants
- Enrollment target
Study Summary
The National Diabetes Prevention Program (NDPP) is a widely available, evidence-based intervention that promotes weight loss to prevent type 2 diabetes; however, participant attendance is problematic and leads to suboptimal weight loss, especially among Hispanic, non-Hispanic black, and low-income non-Hispanic white participants. An innovative pre-session enhancement to the NDPP (Pre-NDPP) showed successful results upon initial application in a diverse and predominately low-income population, with doubled attendance and weight loss outcomes as compared to previous NDPP participants who did not receive a pre-session. If Pre-NDPP is shown to be successful upon more rigorous study, it can be widely adopted by NDPP providers across the country to help reduce diabetes prevalence and related health disparities.
Interventions
- BEHAVIORAL Presessions
- BEHAVIORAL National Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2019-08-06 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04022499
The ClinicalTrials.gov registry entry for NCT04022499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Presessions is the first listed.
NCT04022499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04022499 about?
NCT04022499 is a clinical study titled "Presessions for the National Diabetes Prevention Program". The National Diabetes Prevention Program (NDPP) is a widely available, evidence-based intervention that promotes weight loss to prevent type 2 diabetes; however, participant attendance is problematic and leads to suboptimal weight loss, especially among Hispanic, non-Hispanic black, and low-income n...
What is the current status of trial NCT04022499?
This trial is currently completed. It is a NA study. The enrollment target is 483 participants. The study started on 2019-08-06. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT04022499?
The interventions under investigation include: Presessions (BEHAVIORAL), National Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04022499?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.